Pharmaceuticals
The pharmaceutical industry is a EUR 1 trillion sector and has been a major engine of economic growth and scientific advancement for decades. The industry encompasses a wide range of enterprises including large ethical drug multi-nationals (so-called Big Pharma), mid-sized specialty pharmaceutical companies, generic manufacturers, virtual pharmas, small biotechnology and biopharmaceutical firms, and all the various ancillary support and service companies that provide contract research, regulatory guidance, contract sales, and manufacturing technologies and raw materials.
Although growth has not been as robust in recent years—mainly due to price pressures, uncertainty in regulatory/reform measures, and weak drug pipelines— the demographic and structural drivers of demand in healthcare still exist: namely, the continued aging of the global population and the increasing sophistication and wealth of developing nations. Shifting epidemiology patterns and outbreaks, along with new challenges in chronic disease, cancer, heart disease, and degenerative disease will continue to impel the need for ever-better medicines. New understanding and technologies in drug delivery, and most especially in the fields of genomics, proteomics, and molecular biology generally, also hold promise for better therapeutics and a revival of profits.
Although growth has not been as robust in recent years—mainly due to price pressures, uncertainty in regulatory/reform measures, and weak drug pipelines— the demographic and structural drivers of demand in healthcare still exist: namely, the continued aging of the global population and the increasing sophistication and wealth of developing nations. Shifting epidemiology patterns and outbreaks, along with new challenges in chronic disease, cancer, heart disease, and degenerative disease will continue to impel the need for ever-better medicines. New understanding and technologies in drug delivery, and most especially in the fields of genomics, proteomics, and molecular biology generally, also hold promise for better therapeutics and a revival of profits.
Page 1/16
Biotechnology in the United Kingdom
August 2013 · MarketLine
Biotechnology in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Saudi Arabia
August 2013 · MarketLine
OTC Pharmaceuticals in Saudi Arabia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Italy
August 2013 · MarketLine
OTC Pharmaceuticals in Italy industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
Biotechnology in Italy
August 2013 · MarketLine
Biotechnology in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00
Global Biotechnology
August 2013 · MarketLine
Global Biotechnology industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00
Generics in France
August 2013 · MarketLine
Generics in France industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00
Generics in China
August 2013 · MarketLine
Generics in China industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00
Generics in Asia-Pacific
August 2013 · MarketLine
Generics in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Spain
August 2013 · MarketLine
OTC Pharmaceuticals in Spain industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in the United Kingdom
August 2013 · MarketLine
OTC Pharmaceuticals in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
Biotechnology in Spain
August 2013 · MarketLine
Biotechnology in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Singapore
August 2013 · MarketLine
OTC Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
Generics in Spain
August 2013 · MarketLine
Generics in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Europe
August 2013 · MarketLine
OTC Pharmaceuticals in Europe industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
Generics in Italy
August 2013 · MarketLine
Generics in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00
Generics in Belgium
August 2013 · MarketLine
Generics in Belgium industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Brazil
August 2013 · MarketLine
OTC Pharmaceuticals in Brazil industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
Biotechnology in Canada
August 2013 · MarketLine
Biotechnology in Canada industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00
Global OTC Pharmaceuticals
August 2013 · MarketLine
Global OTC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
Generics in Europe
August 2013 · MarketLine
Generics in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00
Generics in the United Kingdom
August 2013 · MarketLine
Generics in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00
Biotechnology in France
August 2013 · MarketLine
Biotechnology in France industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in the Netherlands
August 2013 · MarketLine
OTC Pharmaceuticals in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
Biotechnology in the Netherlands
August 2013 · MarketLine
Biotechnology in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00
Generics in Canada
August 2013 · MarketLine
Generics in Canada industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in China
August 2013 · MarketLine
OTC Pharmaceuticals in China industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Switzerland
August 2013 · MarketLine
OTC Pharmaceuticals in Switzerland industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in the United States
August 2013 · MarketLine
OTC Pharmaceuticals in the United States industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Canada
August 2013 · MarketLine
OTC Pharmaceuticals in Canada industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
Global Generics
August 2013 · MarketLine
Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00
Biotechnology in Germany
August 2013 · MarketLine
Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Hungary
August 2013 · MarketLine
OTC Pharmaceuticals in Hungary industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
Generics in the Netherlands
August 2013 · MarketLine
Generics in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Asia-Pacific
August 2013 · MarketLine
OTC Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Mexico
August 2013 · MarketLine
OTC Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
Biotechnology in Belgium
August 2013 · MarketLine
Biotechnology in Belgium industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Japan
August 2013 · MarketLine
OTC Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
Generics in Germany
August 2013 · MarketLine
Generics in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00
Biotechnology in Europe
August 2013 · MarketLine
Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in India
August 2013 · MarketLine
OTC Pharmaceuticals in India industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Germany
August 2013 · MarketLine
OTC Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
Biotechnology in Japan
August 2013 · MarketLine
Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Belgium
August 2013 · MarketLine
OTC Pharmaceuticals in Belgium industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
Generics in Japan
August 2013 · MarketLine
Generics in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00
Biotechnology in the United States
August 2013 · MarketLine
Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00
Biotechnology in Asia-Pacific
August 2013 · MarketLine
Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00
Biotechnology in China
August 2013 · MarketLine
Biotechnology in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in France
August 2013 · MarketLine
OTC Pharmaceuticals in France industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
Generics in the United States
August 2013 · MarketLine
Generics in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2007-11, and forecast to 2016). € 259,00
OTC Pharmaceuticals in United Arab Emirates
August 2013 · MarketLine
OTC Pharmaceuticals in United Arab Emirates industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
Options